Amarin Pharma Inc
General
Total Cases48
Active Cases1
Patents71
Ratings
Experience
Grade
Trend
DCT
L1
E
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/02/24 | Official Transcript of Motion to Strike held on 8/29/22 before Judge Jennifer Hall. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/23/2024. Redacted Transcript Deadline set for 3/4/2024. Release of Transcript Restriction set for 5/2/2024. (Warner, Deanna) (Entered: 02/02/2024) | |
| 02/02/24 | Official Transcript of Motion to Strike held on 8/29/22 before Judge Jennifer Hall. Court Reporter Deanna Warner, Email: deanna_warner@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 2/23/2024. Redacted Transcript Deadline set for 3/4/2024. Release of Transcript Restriction set for 5/2/2024. (Warner, Deanna) (Entered: 02/02/2024) | |
| 09/20/23 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,700,537; US 8,642,077; US 10,568,861. (Attachments: # 1 Final Judgment (D.I. 144), # 2 Order (D.I. 154))(nms) (Entered: 09/20/2023) | |
| 09/20/23 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,700,537; US 8,642,077; US 10,568,861. (Attachments: # 1 Final Judgment (D.I. 144), # 2 Order (D.I. 154))(nms) (Entered: 09/20/2023) | |
| 09/19/23 | CASE CLOSED per entry of D.I. 154 . (nms) (Entered: 09/19/2023) | |
| 09/19/23 | CASE CLOSED per entry of D.I. 154 . (nms) (Entered: 09/19/2023) | |
| 02/06/23 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Association for Accessible Medicines. (Schladweiler, Benjamin) (Entered: 02/06/2023) | |
| 02/06/23 | Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Association for Accessible Medicines. (Schladweiler, Benjamin) (Entered: 02/06/2023) | |
| 02/02/23 | DEFICIENCY NOTICE issued by the Court to Association for Accessible Medicines: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) (Entered: 02/02/2023) | |
| 02/02/23 | DEFICIENCY NOTICE issued by the Court to Association for Accessible Medicines: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) (Entered: 02/02/2023) |